Analysis on Survival and Prognostic Factors in Patients with Resectable Pancreatic Adenocarcinoma

被引:8
作者
Lin, Rong [1 ]
Han, Chao-qun [1 ]
Wang, Wei-jun [1 ]
Liu, Jun [1 ]
Qian, Wei [1 ]
Ding, Zhen [1 ]
Hou, Xiao-hua [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; survival; prognosis; lymph node ratio; LONG-TERM SURVIVAL; LYMPH-NODE RATIO; NEOADJUVANT THERAPY; RISK-FACTORS; CANCER; RESECTION; OBESITY; IMPACT; LYMPHADENECTOMY; GEMCITABINE;
D O I
10.1007/s11596-017-1780-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survival after pancreatic cancer surgery is extremely unfavorable even after curative resection. Prognostic factors have been explored but remain largely undefined. The present study was to identify the role of clinical and laboratory variables in the prognostic significance of resectable pancreatic adenocarcinoma. A total of 96 patients who underwent curative resection for pancreatic cancer were included. Survival was evaluated based on complete follow-up visits and was associated with potential prognostic factors using the Kaplan-Meier method and Cox proportional hazard model survival analyses. The results showed that prognostic variables significantly reduced survival, including old age, poorly differentiated tumors, elevated tumor markers and positive lymph node metastasis (LNM). Age of older than 60 years (HR=1.83, P=0.04), LNM (HR=2.22, P=0.01), lymph node ratio (0<LNR <= 0.2, HR=1.38, P=0.042; LNR>0.2, HR=1.92, P=0.017), initial CA199 (HR=4.80, P=0.004), and CEA level (HR=2.59, P=0.019) were identified as independent prognostic factors by multivariate analysis. It was concluded that LNR may be potent predictor of survival and suggests that surgeons and the pathologists should thoroughly assess lymph nodes prior to surgery.
引用
收藏
页码:612 / 620
页数:9
相关论文
共 41 条
[1]  
[Anonymous], SCI REP UK
[2]   Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Surgical treatment [J].
Benassai, G. ;
Quarto, G. ;
Perrotta, S. ;
Furino, E. ;
Benassai, G. L. ;
Amato, B. ;
Bianco, T. ;
De Palma, G. ;
Forestieri, P. .
INTERNATIONAL JOURNAL OF SURGERY, 2015, 21 :S1-S3
[3]   Validation of the 6th Edition AJCC Pancreatic Cancer Staging System - Report from the National Cancer Database [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Ritchey, Jamie ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. .
CANCER, 2007, 110 (04) :738-744
[4]  
Bolm L, 2015, ANTICANCER RES, V35, P4105
[5]   Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients [J].
Chen, Ye ;
Gao, She-Gan ;
Chen, Jian-Min ;
Wang, Gong-Ping ;
Wang, Zeng-Fang ;
Zhou, Bo ;
Jin, Can-Hui ;
Yang, Yan-Tong ;
Feng, Xiao-Shan .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (03) :1287-1291
[6]   Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer [J].
Chiang, Kun-Chun ;
Yeh, Chun-Nan ;
Ueng, Shir-Hwa ;
Hsu, Jun-Te ;
Yeh, Ta-Sen ;
Jan, Yi-Yin ;
Hwang, Tsann-Long ;
Chen, Miin-Fu .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
[7]   Influence of Obesity and Other Risk Factors on Survival Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer [J].
Dandona, Monica ;
Linehan, David ;
Hawkins, William ;
Strasberg, Steven ;
Gao, Feng ;
Wang-Gillam, Andrea .
PANCREAS, 2011, 40 (06) :931-937
[8]   Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials [J].
Dasari, Bobby V. M. ;
Pasquali, Sandro ;
Vohra, Ravinder S. ;
Smith, Andrew M. ;
Taylor, Mark A. ;
Sutcliffe, Robert P. ;
Muiesan, Paolo ;
Roberts, Keith J. ;
Isaac, John ;
Mirza, Darius F. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2015, 19 (09) :1725-1732
[9]   Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma [J].
Du, Lingling ;
DeFoe, Melissa ;
Ruzinova, Marianna B. ;
Olsen, Jeffrey R. ;
Wang-Gillam, Andrea .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (04) :717-+
[10]   Prognostic factors in the palliation of pancreatic cancer [J].
Engelken, FJF ;
Bettschart, V ;
Rahman, MQ ;
Parks, RW ;
Garden, OJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (04) :368-373